Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.
OpenAlex 토픽 ·
Botulinum Toxin and Related Neurological Disorders
Pain Management and Treatment
Peripheral Nerve Disorders
[INTRODUCTION] Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors.
APA
Francesco Sartori, Albert Puig-Diví, Javier Picañol (2025). Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.. Neurology international, 17(3). https://doi.org/10.3390/neurolint17030034
MLA
Francesco Sartori, et al.. "Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.." Neurology international, vol. 17, no. 3, 2025.
PMID
40137455
Abstract
[INTRODUCTION] Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors. While various treatments exist, options for refractory cases are limited. Ultrasound-guided percutaneous peripheral nerve stimulation (pPNS), commonly used in pain management, has not been studied for its potential use in spasticity management. This case report aims to evaluate the sensorimotor effects of pPNS in a patient with severe PSS.
[CASE DESCRIPTION] A 38-year-old male with severe PSS and functional limitations post-ischemic stroke in the middle cerebral artery underwent a six-week pPNS protocol (12 sessions). Low-frequency (2 Hz) stimulation targeted the median, musculocutaneous, and anterior interosseous nerves, while medium-frequency (10 Hz) stimulation targeted the posterior interosseous and radial nerves. Spasticity was assessed using the Modified Ashworth Scale (MAS) and Tardieu Scale (TS). Somatosensory assessments included tactile thresholds, pressure pain thresholds, and conditioned pain modulation (CPM).
[OUTCOMES] Spasticity decreased significantly, with reductions of 60.4% and 67.0% in elbow and wrist MAS scores, respectively, and a 49.5% reduction in TS scores. However, spasticity levels returned to baseline between sessions. Somatosensory assessments revealed increased tactile thresholds, decreased pressure pain thresholds, and an 81.3% reduction in CPM. The intervention was well tolerated, with minor transient effects, and the patient preferred pPNS over botulinum toxin injections.
[CONCLUSIONS] pPNS may effectively reduce spasticity and modulate somatosensory thresholds in PSS. These preliminary findings highlight its potential as an alternative treatment for refractory PSS, warranting further research with larger sample sizes and control groups to assess its broader clinical applicability.
[CASE DESCRIPTION] A 38-year-old male with severe PSS and functional limitations post-ischemic stroke in the middle cerebral artery underwent a six-week pPNS protocol (12 sessions). Low-frequency (2 Hz) stimulation targeted the median, musculocutaneous, and anterior interosseous nerves, while medium-frequency (10 Hz) stimulation targeted the posterior interosseous and radial nerves. Spasticity was assessed using the Modified Ashworth Scale (MAS) and Tardieu Scale (TS). Somatosensory assessments included tactile thresholds, pressure pain thresholds, and conditioned pain modulation (CPM).
[OUTCOMES] Spasticity decreased significantly, with reductions of 60.4% and 67.0% in elbow and wrist MAS scores, respectively, and a 49.5% reduction in TS scores. However, spasticity levels returned to baseline between sessions. Somatosensory assessments revealed increased tactile thresholds, decreased pressure pain thresholds, and an 81.3% reduction in CPM. The intervention was well tolerated, with minor transient effects, and the patient preferred pPNS over botulinum toxin injections.
[CONCLUSIONS] pPNS may effectively reduce spasticity and modulate somatosensory thresholds in PSS. These preliminary findings highlight its potential as an alternative treatment for refractory PSS, warranting further research with larger sample sizes and control groups to assess its broader clinical applicability.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | musculocutaneous
|
scispacy | 1 | ||
| 해부 | radial nerves
|
scispacy | 1 | ||
| 해부 | elbow
|
scispacy | 1 | ||
| 약물 | PSS
→ Post-stroke spasticity
|
scispacy | 1 | ||
| 약물 | CPM
→ conditioned pain modulation
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION] Post-stroke
|
scispacy | 1 | ||
| 질환 | Post-Stroke Spasticity
|
scispacy | 1 | ||
| 질환 | stroke
|
C0038454
Cerebrovascular accident
|
scispacy | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | post-ischemic stroke
|
scispacy | 1 | ||
| 질환 | somatosensory
|
scispacy | 1 | ||
| 기타 | Post-Stroke
|
scispacy | 1 | ||
| 기타 | peripheral nerve
|
scispacy | 1 | ||
| 기타 | cerebral artery
|
scispacy | 1 | ||
| 기타 | anterior interosseous nerves
|
scispacy | 1 | ||
| 기타 | posterior interosseous
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.